Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00121134
Status:
COMPLETED
Last Update Posted:
2013-12-24
First Post:
2005-07-13
Brief Title:
Bevacizumab With or Without Cyclophosphamide and Methotrexate A Pilot Study in Women With Operable Breast Cancer
Sponsor:
Harold J Burstein MD PhD
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
05-055
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Harold J Burstein MD PhD
Lead Sponsor Class:
OTHER
Responsible Party:
Harold J Burstein MD PhD
Responsible Party Title:
Associate Professor of Medicine
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of North Carolina | OTHER |
| Genentech Inc | INDUSTRY |
| Beth Israel Deaconess Medical Center | OTHER |
| Indiana University School of Medicine | OTHER |
| University of California San Francisco | OTHER |